| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.12B | 831.37M | 916.33M | 583.32M | 567.82M |
| Gross Profit | 794.92M | 414.20M | 565.80M | 513.31M | 568.11M |
| EBITDA | 285.73M | 72.12M | 216.79M | 98.99M | 221.23M |
| Net Income | 224.13M | 223.01M | 165.49M | 71.89M | 147.37M |
Balance Sheet | |||||
| Total Assets | 18.93B | 18.15B | 18.72B | 18.02B | 17.60B |
| Cash, Cash Equivalents and Short-Term Investments | 2.54B | 2.26B | 2.74B | 2.76B | 5.51B |
| Total Debt | 1.12B | 849.80M | 1.11B | 1.72B | 550.97M |
| Total Liabilities | 16.80B | 16.19B | 17.06B | 16.52B | 15.85B |
| Stockholders Equity | 2.12B | 1.96B | 1.66B | 1.49B | 1.74B |
Cash Flow | |||||
| Free Cash Flow | 243.90M | 88.34M | 148.23M | 262.50M | 317.57M |
| Operating Cash Flow | 243.90M | 116.93M | 196.89M | 296.52M | 348.77M |
| Investing Cash Flow | -586.20M | 284.59M | -411.17M | -2.28B | -1.01B |
| Financing Cash Flow | 443.05M | -809.62M | 455.04M | 451.84M | 970.57M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $2.67B | 10.90 | 9.47% | 3.72% | -1.76% | 32.44% | |
78 Outperform | $3.16B | 11.35 | 9.82% | 3.79% | 5.15% | 16.42% | |
75 Outperform | $2.52B | 11.60 | 11.34% | ― | -0.37% | -20.30% | |
74 Outperform | $2.53B | 22.78 | 6.39% | 1.69% | -5.72% | -3.86% | |
69 Neutral | $2.51B | 11.45 | 7.49% | 3.27% | -1.58% | 6.34% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $2.67B | 12.05 | 10.98% | 2.38% | 17.95% | ― |
Trustmark Corporation has announced a new stock repurchase program effective January 1, 2026, allowing for the acquisition of up to $100 million of its common shares by December 31, 2026. This program replaces the previous one set to expire on December 31, 2025, and offers flexibility in purchasing shares based on market conditions, with no obligation on the number or value of shares repurchased.
The most recent analyst rating on (TRMK) stock is a Hold with a $42.00 price target. To see the full list of analyst forecasts on Trustmark stock, see the TRMK Stock Forecast page.